当前位置: X-MOL 学术Cancer Cell › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma
Cancer Cell ( IF 48.8 ) Pub Date : 2022-05-08 , DOI: 10.1016/j.ccell.2022.05.003
Julius C Enssle 1 , Julia Campe 2 , Sarah Büchel 2 , Alina Moter 2 , Frederic See 2 , Katharina Grießbaum 2 , Michael A Rieger 3 , Sebastian Wolf 1 , Olivier Ballo 4 , Björn Steffen 4 , Hubert Serve 1 , Holger F Rabenau 5 , Marek Widera 5 , Melanie Bremm 6 , Sabine Huenecke 6 , Sandra Ciesek 7 , Ivana von Metzler 1 , Evelyn Ullrich 8
Affiliation  

Abstract not available

中文翻译:

多发性骨髓瘤患者对第三剂 BNT162b2 疫苗接种增强但依赖于变异的血清学和细胞免疫反应

摘要不可用
更新日期:2022-05-08
down
wechat
bug